×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.35 | 89.2 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| LUPIN LTD. | 57627.3 | 21280.7 | 57085.9 | 46.48 | 93,534 | 25.3 |
| FORTIS HEALTHCARE LTD. | 4730.4 | 518.8 | 4330.3 | 0.69 | 73831 | 80.2 |
| ABBOTT INDIA LTD. | NA | NA | NA | NA | 65876 | 45.4 |
Lupin Ltd, with Security Code 500257, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,836.3 | 3,495.6 | 3,659.2 | 4,115.8 | 3,395.9 | 4,167.6 | 4,106.2 | 4,208.0 | 4,485.7 | 5,708.6 |
| Expenses | 2,574.1 | 2,790.6 | 2,824.0 | 2,898.4 | 2,695.5 | 2,968.0 | 2,991.5 | 2,797.0 | 2,739.5 | 2,979.0 |
| Operating Profit | 262.2 | 705.0 | 835.2 | 1,217.3 | 700.4 | 1,199.7 | 1,114.8 | 1,411.1 | 1,746.2 | 2,729.6 |
| OPM % | 9.24% | 20.17% | 22.83% | 29.58% | 20.62% | 28.79% | 27.15% | 33.53% | 38.93% | 47.82% |
| Other Income | 55.3 | 27.7 | 25.6 | 23.2 | 31.3 | 38.2 | 32.6 | -21.9 | 48.8 | 54.1 |
| Interest | 29.4 | 16.2 | 15.3 | 11.4 | 13.5 | 13.6 | 17.6 | 19.6 | 33.9 | 18.9 |
| Depreciation | 146.2 | 140.1 | 149.5 | 145.2 | 290.0 | 141.4 | 145.8 | 152.5 | 208.0 | 176.7 |
| Profit before tax | 141.8 | 576.5 | 696.0 | 1,084.0 | 428.2 | 1,082.9 | 984.1 | 1,294.3 | 1,553.2 | 2,588.2 |
| Tax % | -16.1% | -17.3% | -21.2% | -15.5% | -10.3% | -17.9% | -17.9% | -19.1% | -16.9% | 17.8% |
| Net Profit | 119.0 | 477.0 | 548.6 | 916.4 | 384.1 | 889.2 | 807.8 | 984.7 | 1,291.4 | 2,128.1 |
| EPS in Rs | 2.59 | 10.44 | 12.01 | 20.05 | 8.4 | 19.44 | 17.66 | 21.52 | 0 | 46.48 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,322.2 | 4,430.1 | 4,814.1 | 5,038.6 | 5,197.4 | 4,960.8 | 5,600.3 | 5,672.7 | 5,767.7 | 5,667.1 |
| Expenses | 3,789.6 | 3,852.3 | 3,957.8 | 4,120.8 | 4,159.5 | 3,963.9 | 4,359.4 | 4,332.4 | 4,411.8 | 4,345.9 |
| Operating Profit | 532.7 | 577.8 | 856.3 | 917.8 | 1,037.9 | 996.9 | 1,241.0 | 1,340.4 | 1,355.9 | 1,321.2 |
| OPM % | 12.32% | 13.04% | 17.79% | 18.21% | 19.97% | 20.09% | 22.16% | 23.63% | 23.51% | 23.31% |
| Other Income | 18.0 | 37.3 | 22.8 | 40.4 | 29.4 | 29.3 | 67.8 | 42.3 | 53.7 | 57.0 |
| Interest | 84.1 | 92.6 | 85.7 | 80.6 | 74.0 | 71.3 | 68.0 | 70.9 | 66.9 | 89.1 |
| Depreciation | 220.4 | 264.0 | 234.7 | 247.9 | 257.2 | 457.1 | 247.7 | 256.9 | 271.5 | 393.2 |
| Profit before tax | 246.1 | 258.5 | 558.8 | 629.7 | 736.1 | 497.7 | 993.0 | 1,054.9 | 1,071.3 | 895.9 |
| Tax % | -36% | -6.2% | -18.9% | -21.3% | -15.9% | -26% | -18.9% | -18.5% | -19.8% | -12.7% |
| Net Profit | 157.7 | 242.4 | 453.3 | 495.3 | 618.7 | 368.2 | 805.5 | 859.5 | 858.9 | 782.4 |
| EPS in Rs | 3.36 | 5.16 | 9.9 | 10.72 | 13.41 | 7.86 | 17.52 | 18.64 | 18.69 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 28% |
| 3 Years: | 173% |
| TTM: | 75% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 17% |
| 3 Years: | 49% |
| 1 Year: | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 8% |
| 3 Years: | 11% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 55% |
| 3 Years: | 60% |
| TTM: | 73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 17% |
| 3 Years: | 49% |
| 1 Year: | 21% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|